FEVER/CONCUSSION
Educational Objectives
| The goal of this program is to improve the management of fever and sports-related concussions in children. After
hearing and assimilating this program, the clinician will be better able to:
|
 | 1. Implement current recommendations for evaluating febrile infants and children in different age groups.
|
 | 2. Choose the appropriate diagnostic test and treatment of urinary tract infections in children.
|
 | 3. Determine when a young athlete with a concussion can return to play.
|
 | 4. Recognize and manage postconcussion syndrome.
|
 | 5. Determine when to perform computed tomography of the head after a concussion.
|
Faculty Disclosure
In adherence to ACCME Standards for Commercial Support, Audio-Digest requires all faculty and members of the planning committee
to disclose relevant financial relationships within the past 12 months that might create any personal conflicts of interest.
Any identified conflicts were resolved to ensure that this educational activity promotes quality in health care and not a proprietary
business or commercial interest. For this program, the faculty and planning committee reported nothing to disclose.
Acknowledgements
Dr. Herold was recorded at 41st Annual Advances and Controversies in Clinical Pediatrics, held May 29-31, 2008, in
San Francisco, CA, and sponsored by the Department of Pediatrics, University of California, San Francisco, School
of Medicine. Dr. Odell was recorded at Current Clinical Pediatrics 2008, held April 21-25, 2008, in Hilton Head Island,
SC, and sponsored by the Boston University School of Medicine. The Audio-Digest Foundation thanks the
speakers and the sponsors for their cooperation in the production of this program.
Approach to Fever in the Era of Pneumococcal Vaccine
Betsy C. Herold, MD, Professor, Department of Pediatrics, Department of Microbiology and Immunology, and Department
of Obstetrics & Gynecology and Womens Health, Albert Einstein College of Medicine of Yeshiva University,
New York, NY
| Fever: among most common reasons parents seek medical attention; accounts for ≈25% of emergency department (ED)
and office visits; majority of patients have self-limited illness
|
| Common diagnoses (by age group) of children with fever: majority have self-limited viral illness not identified;
infants <1 mo of ageoccult bacteremia and meningitis; pathogen most often Escherichia coli, less often group
B streptococci, Listeria, Streptococcus pneumoniae, other enteric bacteria, and Staphylococcus aureus; urinary tract
infections (UTIs) common; viruses, ie, enterovirus and herpesvirus; infants 1 to 3 mo of ageoccult bacteremia; if
meningitis seen, most likely meningococcus; late-onset group B streptococcal disease (prophylaxis does not prevent
late-onset disease, only early-onset disease); UTIs and bone disease; children between 3 mo and 3 yr of ageoccult
bacteremia and UTIs
|
| Occult bacteremia: in all studies, S pneumoniae main pathogen, followed by Haemophilus influenzae type b (Hib);
remainder primarily Neisseria meningitidis, Salmonella, and others; development of meningitis depends on pathogen
(most common with N meningitidis, least common with S pneumoniae)
|
| Era of oral antibiotics: studylooked at febrile children (3-36 mo of age) presenting to ED and clinics who looked
well; patients randomized to oral amoxicillin or placebo; no difference in major morbidities, with trend toward earlier
resolution of fever in those who received amoxicillin; decision-analysis approachmost studies concluded that obtaining
complete blood cell count (CBC), targeting children with high or low white blood cell (WBC) counts, and treating
them best option
|
| Era of ceftriaxone (1993): first major study519 febrile high-risk children randomized to oral amoxicillin or intramuscular
ceftriaxone; more patients receiving oral treatment had persistent fever, but otherwise, no difference in outcome;
second study≈6000 febrile high-risk children; randomized to oral amoxicillin or ceftriaxone; most of children
with bacteremia had S pneumoniae; no difference in major morbidities, but fewer children in ceftriaxone group had persistent
fever; ceftriaxone became standard of care for occult bacteremia
|
| Hib vaccine and prevalence of occult bacteremia: 2 post-Hib vaccine studies on incidence of bacteremia (incidences
of 1.6% and 1.9% found); S pneumoniae most common pathogen isolated (92% and 83%); 96% of children recovered
without antibiotics (most S pneumoniae infections transient bacteremia and self-limited); rate of developing
sepsis or meningitis, 1 in 3000; peak incidence of invasive pneumococcal disease seen in children 1 to 2 yr of age
|
| High-risk populations: HIV-infected children; immunocompromised hosts; those with asplenia; children with cochlear
implants; certain ethnic groups; elderly
|
| Conjugate pneumococcal vaccine (March 2000): recommended for children 6 wk to 5 yr of age (allowed for
children ≤9 yr of age); contains 7 capsular serotypes conjugated to diphtheria toxin; serotypes accounted for almost
90% of invasive disease and 75% of noninvasive disease; conjugation means vaccine T-cell-dependent, leading to good
T-cell response, memory response, and strong booster response upon reexposure; leads to large decline in overall invasive
disease and noninvasive disease (including otitis media) in all age groups; herd immunity effect strong; however,
replacement disease (2 types) increased, including expansion in isolation of serotypes not present in vaccine; mechanisms
include capsular switching
|
| Laboratory testing in postvaccine era: postpneumococcal vaccine study looked at whether WBC count necessary;
found sensitivity good but specificity poor; no studies document value of WBC count in predicting meningococcal bacteremia;
C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) not documented as helpful in meningococcal,
Salmonella, or group A streptococcal disease; sensitivity of single blood culture ≈80%, and specificity 95% to 99%
|
| Infants <3 mo of age: serious bacterial infections seen in greater proportion of infants <3 mo than in older children;
low-risk infants include those with no clinical findings on examination, WBC counts of 5000 to 15,000/µL, <1500
bands/mm3 , and normal urinalysis (UA); study found that only 1 in 144 infants who met criteria for low risk had serious
bacterial illness (none bacteremic); those who did not meet criteria (22 of 89) considered high risk and had serious
illness (prevaccine era); low-risk infantsfull term; no perinatal antibiotics; no previous hospitalizations or chronic
illnesses; WBC count of 5000 to 15,000/µL, without shift to left; normal UA (<10 WBC/hpf); negative predictive value
almost 100%; meta-analysis of studies of febrile infants <3 mo of age found that in high-risk group, risk for serious
bacterial illness (24%), bacteremia (13%), and meninigitis (4%) present; in low-risk group, 2.6%, 1.3%, and 0.6%, respectively
|
| Current recommendations (based on literature and speakers opinion): infant <1 mo of ageobtain
work-up that includes CBC with differential and platelet count, UA, blood and urine cultures, and lumbar puncture;
chest x-ray only if clinically warranted; most experts (including speaker) would admit infant to hospital (but not necessarily
give antibiotics); empiric treatment with ampicillin and gentamicin or ampicillin and cefotaxime; if high rate of
methicillin-resistant S aureus (MRSA) present in institution, vancomycin and cefotaxime given (note, referring to low-
risk infant); ampicillin not recommended for Listeria (vancomycin better option); consider herpes simplex virus (HSV)
in diagnosis and treat if suggestion of HSV present; infant 1 to 3 mo of agesame work-up (CBC with differential and
platelet count and UA); lumbar puncture not routine; if family reliable, with access to medical care, and infant low-risk
(per Rochester criteria), may discharge patient home; if medical access is concern, admit and observe; if infant high-
risk, admit and treat empirically; infant 3 to 36 mo of agein immunized children, occult bacteremia rare; UA still
necessary (UTI most common infection in this age group); need for CBC unknown; use clinical judgment to select
those at risk for N meningitidis; unvaccinated children more concerning; infants who have not received conjugate vaccine
managed according to existing practice guidelines
|
| Urinary tract infection: most common cause of fever in infants; prevalence 3% to 7%; overall, more common in girls,
but more common in boys in first few months after birth; increased likelihood of UTI in febrile childrenhistory of
UTI; temperature >40°C; suprapubic tenderness; for boys, lack of circumcision; circumcision only protective finding; diagnostic
testspositive predictive value (PPV) of pyuria (hemocytometric count on unspun urine) with bacteriuria,
85%; empiric treatment recommended before culture results available; lower PPV if only pyuria or only bacteriuria
present and likelihood of UTI only 40% (delaying antibiotics recommended); management of asymptomatic bacteriuria
controversial; routine ultrasonography (US) not recommended; voiding cystourethrography (VCUG) likely still indicated
at 1 mo and dimercaptosuccinic acid (DMSA) scintigraphy 6 mo later to identify scarring; incidence of scarring after
pyelonephritis ≈40%; dipstick not helpful in pediatrics; treatmenttraditional therapy antibiotics; ampicillin and
gentamicin number one recommendation; all studies looking at oral therapy conducted with cefixime (Suprax); not
known whether oral nitrofurantoin, oral trimethoprim-sulfamethoxazole, and oral ampicillin as effective as intravenous
therapy; prophylactic use of antibiotics (pending imaging studies) still recommended but somewhat controversial
|
Sports-Related Concussion
Christine A. Odell, MD, Assistant Professor of Pediatrics, Boston University School of Medicine, Boston, MA
| Pathophysiology: head injury triggers release of excitatory neurotransmitters, followed by massive ion influx and
brief period of hyperglycolysis; followed by persistent metabolic instability, mitochondrial dysfunction, decreased cerebral
blood flow, and glucose metabolism; may result in axonal injury and neuronal dysfunction, with neurologic deficits,
cognitive impairment, and somatic symptoms (postconcussion syndrome)
|
| Present definition: involves alteration in consciousness (ie, patient confused, dazed, and disoriented, with or without
loss of consciousness [LOC]); patient may have anterograde and retrograde amnesia; may be associated with lethargy,
delirium, brief seizure, blurred vision, dizziness, headache, nausea, and vomiting; blow to head may result in confusional
state (commonly referred to as ding [actually concussion]); definition of concussion does not require LOC
>90% of athletic concussions do not involve LOC; when sports injury occurs with LOC, LOC usually brief (seconds)
and does not correlate with severity of concussion as defined by number, duration, and intensity of symptoms
|
| Evaluation of athlete: baseline cognitive and postural stability testing recommended; on-the-field evaluation for
signs and symptoms of concussion, neck injury, or other associated injuries; child with neck injury needs immediate
immobilization and transport to trauma center or ED; grading systemsless important than clinical symptoms exhibited
at time of evaluation and over time; in athlete with head injury, evaluate for altered mental status; determine
whether child appears dazed, has confusion, forgetfulness, slowed response to questions, personality change, LOC,
and/or retrograde amnesia; symptoms include headache, dizziness or balance problems, sensitivity to light or noise,
feeling foggy or groggy, feeling slowed down, difficulty concentrating, and perceived memory loss; severity of
concussiondetermined by severity and persistence of signs and symptoms; eg, mild concussion may present as
ding, very short period of confusion, prompt return to normal, and no other signs and symptoms; more severe concussion
may include prolonged anterograde and retrograde amnesia, persistent confusion, slow response to questions, and
somnolence; include formal cognitive and postural stability testing if possible; check vital signs and perform neurologic
examination every 5 min until patient normalizes or clinical improvement seen
|
| Return to play: assess whether all signs and symptoms of concussion have resolved at rest and with mild exertion (mild
exercises that simulate sport but do not put child at risk for head injury); controversial recommendationathletes with
mild symptoms of head injury that resolve in <20 min may return to play, but must be monitored closely during practice
or game, on sideline, and again at 24 to 48 hr for recurrence of symptoms; speaker wary of this recommendation, citing
data showing that 33% of athletes with concussion who returned to play on same day had delayed symptoms (3 hr after
injury), compared to 12.6% who did not return to play; if LOC or amnesia have occurred, child should not return to play
on day of injury; athletes with history of concussion at increased risk for repeat injury and slow recovery from postconcussion
signs and symptoms, cognitive dysfunction, and postural instability with repeat concussion; assess each athlete
individually
|
| Second-impact syndrome (SIS): potentially lethal condition that occurs when young athlete still symptomatic from
previous brain injury sustains concussion; likely caused by loss of autoregulation of cerebral blood flow with subsequent
vascular engorgement; almost all reported cases in young athletes (<19 yr of age); younger athletes recover more
slowly than older athletes; because damage to maturing brain of young athlete possibly severe, younger the athlete, the
more conservatively he or she should be managed; 300% increase in risk for concussion after 3 concussions in 7-yr period;
players with 2 concussions have longer time to symptom resolution after subsequent injuries; in 92% of cases, recurrent
in-season injury occurs in ≤10 days of initial injury; do not allow athlete to play after third concussion of season
|
| Postconcussion syndrome: symptoms in 3 of following categories, eg, headache, dizziness, fatigue, noise intolerance,
irritability, depression, anxiety, emotional lability, subjective concentration problems, memory loss, intellectual
difficulties, insomnia, reduced alcohol tolerance, preoccupation with symptoms, fear of brain damage; studycollege
football players with concussions vs controls; 91% of players with concussions returned to personal baseline in 7 days
(100% in 90 days); cognitive impairment most severe at time of injury and usually persisted until postinjury day 2, then
steadily improved; only 77.8% of athletes with concussion had LOC or amnesia; studyathletes, 13 to 24 yr of age;
considered use of functional magnetic resonance imaging (MRI) and clinical and neuropsychologic tests 1 wk after injury
and at time of clinical recovery of standardized tests; initial changes in brain physiology linked to self-reported
symptoms, neuropsychologic test results, and clinical recovery; confirmed that neurophysiologic abnormalities occur
after even mild sports-related concussion
|
| Current recommendations: most high school and college athletes return to play 3 to 5 days after concussion; data
suggest 7 days better; however, 9% of athletes still not at baseline by 7 days and should not return to play until all signs
and symptoms of concussion and cognitive and postural stability testing have returned to normal, or to athletes baseline
|
| Glasgow Coma Scale (GCS): used to assess changes in mental status; lowest score 3; highest score 15; GCS score of
13 to 15 considered mild head injury (concussion usually in this category)
|
| Computed tomography (CT) of head: <10% of children with concussion have intracranial injuries identified by
head CT; <2% with abnormalities require neurosurgery; normal neurologic examination does not predict normal head
CT; New Orleans decision rule for head CT after concussion applicable only if patients GCS score 15; abnormal
CT more likely if patient has headache, vomiting, age >60 yr, drug or alcohol intoxication, persistent anterograde amnesia,
evidence of soft tissue or bone injury above clavicles, or seizure; Canadian head CT ruleapplies to patients
with GCS scores of 13 to 15 and age 16 yr; found high risk for neurosurgical intervention with GCS score <15 ≤2 hr after
injury, suspected open or depressed skull fracture, any sign of basilar skull fracture, >2 episodes of vomiting, and
advanced age; moderate risk for brain injury detected by CT if retrograde amnesia persists ≥30 min and if dangerous
mechanism present (eg, pedestrian struck by car, ejection from motor vehicle injury, fall from 3 ft or 5 stairs [eg, gymnastics,
diving]); University of California, Davis, predictorsscalp hematoma; signs of skull fracture; abnormal mental
status (GCS score <15 or if patient confused, somnolent, repetitive, or slow to respond to verbal communication);
vomiting; headache; take-home pointsno criteria 100% sensitive and 100% specific; speaker combines criteria from
all studies, and utilizes head CT if any of criteria observed; radiation exposure for CT highest for children <5 yr of age,
especially if dose not adjusted for childs size
|
| Observation after concussion: CT showing small brain contusions or subarachnoid hemorrhage indicates severe
impact and warrants further evaluation by neurologic or trauma surgeon and observation; skull fracture in middle
meningeal artery distribution presents risk for epidural hematoma (also warrants neurosurgical consultation); persistence
of altered mental status or decrease in mental status warrants hospital observation; if mental status and neurologic
examination remain normal after observation period (4 hr from time of injury), patient discharged to care of responsible
person; deterioration in mental status warrants CT; role of wake-up calls controversial; probably indicated (but no good
data) if patient has experienced LOC, prolonged amnesia, and persistence of symptoms
|
Suggested Reading
Atabaki SM et al: A clinical decision rule for cranial computed tomography in minor pediatric head trauma. Arch Pediatr
Adolesc Med 162:439, 2008; Bauer R et al: New developments in the diagnosis and management of pediatric UTIs. Urol
Clin North Am 35:47, 2008; Broshek DK et al: Sex differences in outcome following sports-related concussion. J Neurosurg
102:856, 2005; Cuff S et al: Validation of a relative head injury severity scale for pediatric trauma. J Trauma 63:172,
2007; Gabriel ME et al: Management of febrile children in the conjugate pneumococcal vaccine era. Clin Pediatr (Phila)
43:75, 2004; Ishimine P: Fever without source in children 0 to 36 months of age. Pediatr Clin North Am 53:167, 2006;
Kirkwood MW et al: Pediatric sport-related concussion: a review of the clinical management of an oft-neglected population.
Pediatrics 117:1359, 2006; Sim A et al: Prolonged recovery of memory functioning after mild traumatic brain injury in adolescent
athletes. J Neurosurg 108:511, 2008; Stoll ML et al: Incidence of occult bacteremia among highly febrile young children
in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent
Care Center. Arch Pediatr Adolesc Med 158:671, 2004; Sur DK et al: Evaluating fever of unidentifiable source in young
children. Am Fam Physician 75:1805, 2007; Thiessen ML et al: Pediatric minor closed head injury. Pediatr Clin North
Am 53:1, 2006.
|